Your shopping cart is currently empty

PF-06305591 dihydrate is a potent and highly selective voltage-gated sodium channel NaV1.8 blocker (IC50 = 15 nM) with excellent preclinical in vitro ADME and safety profiles [1].
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 100 mg | $1,440 | 10-14 weeks | 10-14 weeks |
| Description | PF-06305591 dihydrate is a potent and highly selective voltage-gated sodium channel NaV1.8 blocker (IC50 = 15 nM) with excellent preclinical in vitro ADME and safety profiles [1]. |
| Targets&IC50 | NaV1.8:1.5 nM |
| In vitro | PF-06305591 (compound 9) exhibits a highly favorable profile, demonstrating selectivity for NaV channels, minimal hERG activity, effective passive permeability, and strong in vitro metabolic stability [1]. |
| In vivo | PF-06305591 (compound 9) demonstrates significant bioavailability in rats and provides an opportunity to explore increased multiples of Nav1.8 blockade in clinical settings, thereby enabling a comprehensive assessment of NaV1.8's function in pain management [1]. |
| Molecular Weight | 310.39 |
| Formula | C15H26N4O3 |
| Smiles | #N/A |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.